Source: MarketScreener

EmendoBio: AnGes : Notice of Business Restructuring at Consolidated Subsidiary

AnGes Inc. hereby announce that we have decided to proceed with the reorganization of the business of our consolidated subsidiary EmendoBio Inc. ("EmendoBio"), which we announced on January 29, 2024.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Naoya Satoh's photo - CEO of EmendoBio

CEO

Naoya Satoh

CEO Approval Rating

- -/100

Read more